Market Capitalization (Millions $) |
- |
Shares
Outstanding (Millions) |
39 |
Employees |
- |
Revenues (TTM) (Millions $) |
70 |
Net Income (TTM) (Millions $) |
-33 |
Cash Flow (TTM) (Millions $) |
52 |
Capital Exp. (TTM) (Millions $) |
37 |
Spark Therapeutics Inc
Spark Therapeutics Inc is a biopharmaceutical company that focuses on the development of gene therapies for various genetic diseases. The company was founded in 2013 and is headquartered in Philadelphia, Pennsylvania. Spark Therapeutics aims to provide long-lasting treatments for patients with genetic diseases by targeting the underlying cause at the genetic level. One of their most notable achievements is the development and commercialization of the first gene therapy for an inherited retinal disease. The company is actively involved in research and clinical trials to expand its portfolio of gene therapies for other genetic disorders. Spark Therapeutics has collaborations with various organizations, including pharmaceutical companies and research institutions, to advance gene therapy research and development.
Company Address: 3737 Market Street Philadelphia 19104 PA
Company Phone Number: 772-7560 Stock Exchange / Ticker: NASDAQ ONCE
|